The results of this multicenter, placebo-controlled, double-blind, randomized controlled clinical trial suggest that combining TangBi Formula with routine treatments may provide a safer and more effective way to alleviate the symptoms of DSPN.

The effect of novel hypoglycemic drugs on all-cause mortality (a) Network diagram. (b) Forest plot. (c) SUCRA and Line plots of the cumulative probabilities. (d) Pairwise comparison.

In this study, we aimed to determine the value of lymphocyte subsets and granulocyte/monocyte markers in predicting the risk of post-acute pancreatitis diabetes mellitus (PPDM-A). Our study is the first to confirm the correlation between PPDM-A and lymphocyte subsets and indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM-A. The interaction mechanism of granulocyte and monocyte surface markers and B lymphocytes on glucose metabolism disorder after AP is worthy of further study.

Missing data handling approach at development stage of prediction model.

This retrospective study of 256 patients reveals a strong correlation between percentage weight change and A1C reduction in patients on long-term GLP-1 RA use. Additionally, patients who lost more weight had significant improvements in dyslipidemia. These findings emphasize weight reduction as a crucial therapeutic target to enhance metabolic outcomes in real-world clinical practice.